PVLA SG&A Expense Growth

Palvella Therapeutics Inc · SG&A Expense Growth

PVLA logo

PVLA SG&A Expense Growth

Latest reported165.16%
PVLA FY SG&A Growth (YoY) (0.00% → 165.16%)
High-resolution chart · PNG

PVLA sg&a expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Palvella Therapeutics Inc SG&A Expense Growth — Annual fiscal periods
Period endingSG&A Expense Growth
165.1581%
93.238%
-81.2256%
-1.7981%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.